Heartflow is a Silicon Valley medical technology company that uses AI and computational fluid dynamics to turn a standard coronary CT scan into a personalized, color-coded 3D model of a patient's heart. Its FFRCT, Plaque and RoadMap analyses help cardiologists diagnose and manage coronary artery disease non-invasively, reducing the need for invasive angiograms. Founded in 2007 and headquartered in San Francisco, Heartflow has analyzed hundreds of thousands of patients across more than 1,500 U.S. hospitals and went public on the Nasdaq (HTFL) in August 2025.
Aram Salzman is the CEO and co-founder of AngioWave Imaging, a Boston-area medtech company building AI that sharpens the blurry, fast-moving X-ray movies cardiologists rely on during heart catheterizations. He is a serial healthcare founder whose earlier company, NovoBiotic Pharmaceuticals, produced teixobactin, the first new class of antibiotic discovered in decades. He also co-founded and exited CRA Health and Boston Lighthouse Innovations.